Demonstrates on-demand drug delivery in implantable devices, suggesting improved treatment options.
Clinical drug delivery requires precise control, yet conventional methods suffer from fluctuating concentrations and low bioavailability. While implantable devices are promising for long-term therapy, wireless dosage control remains challenging. We report an implantable acoustofluidic chip for on-demand drug delivery. Fabricated via soft lithography and two-photon polymerization, the device integrates a drug-loaded hydrogel and a sharp-edge microcantilever array within a polydimethylsiloxane microchannel. Wireless ultrasound actuation induces acoustic streaming via the microcantilever array, generating a net pumping flow to drive drug release. In addition, the device also enables liquid-phase medications to be controllably released when the drug-loaded hydrogel is replaced by a liquid-phase formulation. Biocompatibility evaluation over a 144 h cell co-culture period confirms negligible cytotoxicity of the acoustofluidic chip. This work demonstrates a promising strategy for wireless, programmable implantable drug delivery.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: